1. Overview & Rationale
Cardiovascular disease (CVD) is the leading cause of death in diabetes. The presentation of CVD in this population is often atypical.
The “Silent” Threat: A large proportion of people with diabetes may have no symptoms (silent ischemia) before a fatal or non-fatal myocardial infarction (MI).
Risk Status: People with diabetes are at higher risk of developing heart disease at an earlier age compared to those without diabetes.
The Goal: To identify individuals with established severe coronary artery disease (CAD) who might benefit from revascularization or intensive medical therapy.
2. Screening Modalities
Different tests are used based on the patient’s symptoms and ability to exercise.
A. Resting Electrocardiogram (ECG)
Utility: Can detect previous silent MI, Left Ventricular Hypertrophy (LVH), or rhythm abnormalities.
Limitation: A normal resting ECG does not rule out CAD (it can be normal in >50% of patients with confirmed CAD).
B. Exercise Stress Testing (EST)
Indication: Useful for assessing prognosis in high-risk individuals.
Challenges: Exercise capacity is frequently impaired in people with diabetes due to obesity, neuropathy, or deconditioning, which can limit the test’s accuracy.
C. Stress Imaging (MPI or Echocardiography)
Indication: Used when the patient cannot exercise adequately or has a baseline ECG that is uninterpretable (e.g., Left Bundle Branch Block, LVH, paced rhythm).
Types:
Myocardial Perfusion Imaging (MPI): Uses a vasodilator (e.g., dipyridamole/adenosine) to mimic exercise stress.
Stress Echocardiography: Uses dobutamine to increase heart rate.
D. Coronary Artery Calcium (CAC) Scoring
Utility: Excellent for risk stratification (determining if a patient is low vs. high risk).
Limitation: While it predicts risk, studies have not consistently shown that screening with CAC improves clinical outcomes compared to standard intensive risk factor management.
3. The "Asymptomatic" Controversy (High Yield)
One of the most critical concepts for the CDE exam is whether to screen patients who feel fine.
Routine Screening: Routine screening for CAD in asymptomatic people with diabetes is NOT recommended.
The Evidence: The DIAD Study (Detection of Ischemia in Asymptomatic Diabetics) showed that screening asymptomatic patients with stress imaging did not reduce cardiac events (MI or death) compared to standard care.
Why? Medical management (statins, BP control, A1C control) is now so effective that identifying mild/moderate ischemia early doesn’t necessarily change the treatment plan or outcome.
4. Who Should Be Tested? (The Indications)
While routine screening is out, targeted testing is in.
1. Resting ECG (Baseline & Repeat): Consider for:
Age years.
Duration of diabetes years (Type 1).
Presence of microvascular complications (retinopathy, nephropathy, neuropathy).
Frequency: Repeat every 2 years in these groups.
2. Stress Testing (ECG or Imaging): Mandatory for:
Typical or Atypical cardiac symptoms (e.g., unexplained shortness of breath).
Associated diseases: Peripheral Artery Disease (PAD) or Carotid Artery Disease.
Sedentary individuals planning to begin vigorous or intense exercise.
High-risk occupations (e.g., airline pilots).
5. Diabetes Canada Clinical Practice Guidelines Recommendations
ey takeaways from the “Recommendations” section (Page S175).
Baseline ECG: A resting ECG should be performed in individuals with:
Age years [Grade D, Consensus].
Duration of diabetes years (Type 1) [Grade D, Consensus].
Microvascular complications [Grade D, Consensus].
(Repeat every 2 years).
No Routine Screening: Routine cardiac screening (stress test/imaging) is not recommended for asymptomatic adults with diabetes [Grade A, Level 1A].
Indications for Stress Testing: Stress testing should be performed for:
Typical or atypical cardiac symptoms (e.g., unexplained dyspnea) [Grade C, Level 3].
Signs of associated PAD or Carotid disease [Grade D, Consensus].
Sedentary individuals planning vigorous exercise [Grade D, Consensus].
Choice of Test:
Exercise ECG is the initial test if the patient can exercise and has a normal resting ECG [Grade D, Consensus].
Pharmacologic stress echo or nuclear imaging should be used if the patient cannot exercise or has resting ECG abnormalities [Grade D, Consensus].